Technologies

Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth

  • by

EXOSENS ANNOUNCES 2024 ESTIMATED RESULTS ABOVE IPO GUIDANCE; 2025 GUIDANCE HIGHLIGHTING LOW TWENTIES ADJUSTED EBITDA GROWTH PRESS RELEASEMÉRIGNAC, FRANCE– 8th JANUARY 2025 2024 estimated figures showing strong revenue growth and sustained profitability, above guidance provided… Read More »Exosens announces 2024 estimated results above IPO guidance; 2025 guidance highlighting low twenties adjusted EBITDA growth